The latest from The Washington Times: A drug used to treat erectile disorders that has not been approved by the Food and Drug Administration could have a profound impact on the nation’s ability to manage sexual dysfunction, the American College of Obstetricians and Gynecologists said Monday.
The group, the nations largest medical society, issued a report titled “The Pill: What It’s All About” in which it warned that there was a risk that the widely used antidepressant Prozac could be misused to treat symptoms of erectile disfunction.
“With the emergence of new treatments for sexual dysfunction that can include the use of a combination of hormones and drugs, it is possible that the widespread use of these new treatments will lead to a shift in treatment practices that may lead to unwanted side effects,” the group said.
“Such changes may also lead to unintended consequences that might have adverse health consequences for women.”
The report is the latest salvo in a national debate about the use and misuse of prescription medications.
Last year, a new federal law went into effect that allows prescription drugs to be resold for profit.
A handful of companies have launched their own pill companies, including Cialis and Pfizer.
The companies are also battling a federal judge in California, who has ordered them to stop marketing their drugs for profit, saying they are ineffective and dangerous.
Pfizer, which is owned by the French pharmaceutical company AstraZeneca, said in a statement that it is reviewing the report and will respond with its own analysis.
Cialits website, where patients can submit questions for answers to the questions posed in the report, said that the company does not condone or encourage the misuse of any of its drugs.
Cialis spokeswoman Julie Bering said the company has been a pioneer in using research and clinical trials to develop new drugs for erectile problems and has made clear that its products are safe for women.
“While we respect the court’s decision and our position is that the use or sale of any medication or drug combination is not authorized, Cialic has always acted responsibly by taking appropriate steps to protect our customers,” she said.
“As a pioneer of sexual health, Cincy is committed to improving the safety of the products we sell and, by our own clinical trial data, have shown a substantial reduction in sexual dysfunction.”
Pfizers spokeswoman, Karen DeYoung, said the study was “misleading” and said the pillmaker is reviewing its position.
“We do not encourage women to take any medication and we take our responsibility to our patients and patients’ families very seriously,” she told CNN.
“Our products are approved for use by women for many conditions and, in general, we do not recommend any use for women or any other patient population.”
The National Institutes of Health has funded research on the efficacy of Prozac and other medications that treat erectilia and other sexual dysfunction.
The drug’s makers say that many patients have benefited from its use.
But it has not had widespread approval.
“A pill is a drug.
You can’t give it away,” said Dr. Peter DeFilippis, an associate professor of obstetrics and gynecology at the University of California, Los Angeles.
“It’s not going to be effective, but it’s going to do something.
I’m not sure what it’s supposed to do.
The question is: Does it help people?”
Dr. David C. McAdams, a clinical professor of medicine at the Yale School of Medicine, said it is important to have data to know if a pill is effective.
But he said the evidence is very limited and that the drugs are often overprescribed.
“It’s possible that a few people out there may be using the pill to treat some of these things and may be taking other drugs that have no effect, and that may cause some problems,” he said.